Logo image of NYC

AMERICAN STRATEGIC INVESTMEN (NYC) Stock Fundamental Analysis

NYSE:NYC - New York Stock Exchange, Inc. - US6494393043 - REIT - Currency: USD

13.14  +0.46 (+3.63%)

Fundamental Rating

1

Overall NYC gets a fundamental rating of 1 out of 10. We evaluated NYC against 65 industry peers in the Real Estate Management & Development industry. NYC may be in some trouble as it scores bad on both profitability and health. NYC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NYC had negative earnings in the past year.
In the past year NYC has reported a negative cash flow from operations.
In the past 5 years NYC always reported negative net income.
In the past 5 years NYC always reported negative operating cash flow.
NYC Yearly Net Income VS EBIT VS OCF VS FCFNYC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

The Return On Assets of NYC (-27.73%) is worse than 83.08% of its industry peers.
Looking at the Return On Equity, with a value of -164.27%, NYC is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
ROA -27.73%
ROE -164.27%
ROIC N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
NYC Yearly ROA, ROE, ROICNYC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 31.89%, NYC is in line with its industry, outperforming 60.00% of the companies in the same industry.
NYC's Gross Margin has declined in the last couple of years.
NYC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
NYC Yearly Profit, Operating, Gross MarginsNYC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

NYC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NYC has more shares outstanding
NYC has more shares outstanding than it did 5 years ago.
NYC has a worse debt/assets ratio than last year.
NYC Yearly Shares OutstandingNYC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NYC Yearly Total Debt VS Total AssetsNYC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

NYC has an Altman-Z score of -1.74. This is a bad value and indicates that NYC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.74, NYC is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
NYC has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NYC (4.06) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF N/A
Altman-Z -1.74
ROIC/WACCN/A
WACC4.91%
NYC Yearly LT Debt VS Equity VS FCFNYC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.54 indicates that NYC may have some problems paying its short term obligations.
NYC has a worse Current ratio (0.54) than 83.08% of its industry peers.
NYC has a Quick Ratio of 0.54. This is a bad value and indicates that NYC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.54, NYC is not doing good in the industry: 78.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
NYC Yearly Current Assets VS Current LiabilitesNYC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for NYC have decreased strongly by -79.24% in the last year.
NYC shows a decrease in Revenue. In the last year, the revenue decreased by -2.03%.
NYC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.10% yearly.
EPS 1Y (TTM)-79.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-0.1%
Revenue growth 5Y0.1%
Sales Q2Q%-20.48%

3.2 Future

The Earnings Per Share is expected to decrease by -59.84% on average over the next years. This is quite bad
NYC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y-312.03%
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y3.17%
Revenue Next 3Y2.65%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NYC Yearly Revenue VS EstimatesNYC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
NYC Yearly EPS VS EstimatesNYC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 2026 0 5 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NYC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NYC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NYC Price Earnings VS Forward Price EarningsNYC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NYC is valued a bit cheaper than the industry average as 63.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.06
NYC Per share dataNYC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

A cheap valuation may be justified as NYC's earnings are expected to decrease with -59.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NYC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN STRATEGIC INVESTMEN

NYSE:NYC (6/30/2025, 4:19:34 PM)

13.14

+0.46 (+3.63%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners2.03%
Inst Owner Change84.69%
Ins Owners4.58%
Ins Owner Change8.61%
Market Cap34.56M
Analysts45
Price Target8.16 (-37.9%)
Short Float %0.11%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA 37.06
EPS(TTM)-11.45
EYN/A
EPS(NY)-12.18
Fwd EYN/A
FCF(TTM)-2.01
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS23.41
BVpS32.54
TBVpS32.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.73%
ROE -164.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.89%
FCFM N/A
ROA(3y)-16.26%
ROA(5y)-11.67%
ROE(3y)-75.54%
ROE(5y)-49.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.57%
GM growth 5Y-6.83%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF N/A
Debt/EBITDA 34.7
Cap/Depr 7.01%
Cap/Sales 2.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z -1.74
F-Score4
WACC4.91%
ROIC/WACCN/A
Cap/Depr(3y)13.9%
Cap/Depr(5y)12.89%
Cap/Sales(3y)5.75%
Cap/Sales(5y)5.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-312.03%
EPS Next 2Y-100.83%
EPS Next 3Y-59.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-0.1%
Revenue growth 5Y0.1%
Sales Q2Q%-20.48%
Revenue Next Year3.15%
Revenue Next 2Y3.17%
Revenue Next 3Y2.65%
Revenue Next 5YN/A
EBIT growth 1Y59.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46%
OCF growth 3YN/A
OCF growth 5YN/A